Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity - PubMed (original) (raw)
Comparative Study
Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity
G A Higgs et al. Proc Natl Acad Sci U S A. 1987 Mar.
Abstract
Among the nonsteroid antiinflammatory drugs there is generally a close correlation between the potency of their inhibition of arachidonate cyclooxygenase, and thus prostaglandin production, and their antiinflammatory activity. One anomaly in this generalization is that whereas aspirin and salicylate are equipotent as antiinflammatory agents, salicylate is less active than aspirin in inhibiting prostaglandin production in vitro. Using rats, we have now measured the concentrations of aspirin and salicylate in plasma and in inflammatory exudates after their oral administration and determined their effects on thromboxane B2 production in clotting blood and prostaglandin (PG) E2 concentrations in the exudates. We have also investigated the effects of both drugs, at concentrations achieved in the exudates, on PGE2 production by nonproliferative explants of acutely inflamed tissues. Aspirin is rapidly metabolized, resulting in peak concentrations of salicylate in the plasma and exudate that exceeded peak concentrations of aspirin by 30- to 50-fold. Furthermore, concentrations of aspirin rapidly declined, whereas high concentrations of salicylate persisted in the plasma and in the exudate for up to 6 hr after a single administration of aspirin. Both drugs reduced PGE2 concentrations in inflammatory exudates by 50-70%, but aspirin was considerably more potent than salicylate in inhibiting thromboxane B2 production in clotting blood. The concentration of salicylate found in inflammatory exudates 6 hr after the administration of aspirin was sufficient to reduce PGE2 production in explants by more than 50%. We conclude that the antiinflammatory action of both drugs depends on the inhibition of PGE2 synthesis by salicylate.
Similar articles
- Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans.
Morris HG, Sherman NA, McQuain C, Goldlust MB, Chang SF, Harrison LI. Morris HG, et al. Ther Drug Monit. 1985;7(4):435-8. doi: 10.1097/00007691-198512000-00012. Ther Drug Monit. 1985. PMID: 3866409 - Antiinflammatory action of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy.
Chiabrando C, Castelli MG, Cozzi E, Fanelli R, Campoleoni A, Balotta C, Latini R, Garattini S. Chiabrando C, et al. Eur J Pharmacol. 1989 Jan 17;159(3):257-64. doi: 10.1016/0014-2999(89)90156-8. Eur J Pharmacol. 1989. PMID: 2920775 - Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.
Peskar BM, Hoppe U, Lange K, Peskar BA. Peskar BM, et al. Br J Pharmacol. 1988 Apr;93(4):937-43. doi: 10.1111/j.1476-5381.1988.tb11483.x. Br J Pharmacol. 1988. PMID: 3390662 Free PMC article. - Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
de Gaetano G, Cerletti C, Dejana E, Latini R. de Gaetano G, et al. Circulation. 1985 Dec;72(6):1185-93. doi: 10.1161/01.cir.72.6.1185. Circulation. 1985. PMID: 2998640 Review. - Antiinflammatory drugs and the many mediators of inflammation.
Vane JR. Vane JR. Int J Tissue React. 1987;9(1):1-14. Int J Tissue React. 1987. PMID: 3110088 Review.
Cited by
- Differential analgesic effects of aspirin-like drugs.
Brune K, Menzel-Soglowek S, Zeilhofer HU. Brune K, et al. Drugs. 1992;44 Suppl 5:52-8; discussion 58-9. doi: 10.2165/00003495-199200445-00008. Drugs. 1992. PMID: 1284562 Review. - Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin.
Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson IH, Kelly CJ, Paterson JR. Blacklock CJ, et al. J Clin Pathol. 2001 Jul;54(7):553-5. doi: 10.1136/jcp.54.7.553. J Clin Pathol. 2001. PMID: 11429429 Free PMC article. - Health-promoting substances and heavy metal content in tomatoes grown with different farming techniques.
Rossi F, Godani F, Bertuzzi T, Trevisan M, Ferrari F, Gatti S. Rossi F, et al. Eur J Nutr. 2008 Aug;47(5):266-72. doi: 10.1007/s00394-008-0721-z. Epub 2008 Jul 5. Eur J Nutr. 2008. PMID: 18604621 - Prolate spheroidal hematite particles equatorially belt with drug-carrying layered double hydroxide disks: Ring Nebula-like nanocomposites.
Nedim Ay A, Konuk D, Zümreoglu-Karan B. Nedim Ay A, et al. Nanoscale Res Lett. 2011 Feb 3;6(1):116. doi: 10.1186/1556-276X-6-116. Nanoscale Res Lett. 2011. PMID: 21711652 Free PMC article. - AMPK activation: a therapeutic target for type 2 diabetes?
Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. Coughlan KA, et al. Diabetes Metab Syndr Obes. 2014 Jun 24;7:241-53. doi: 10.2147/DMSO.S43731. eCollection 2014. Diabetes Metab Syndr Obes. 2014. PMID: 25018645 Free PMC article. Review.
References
- Virchows Arch B Cell Pathol. 1970;4(4):303-9 - PubMed
- Nature. 1985 Nov 14-20;318(6042):186-8 - PubMed
- Nat New Biol. 1971 Jun 23;231(25):235-7 - PubMed
- Nat New Biol. 1971 Jun 23;231(25):237-9 - PubMed
- J Pharm Sci. 1972 Mar;61(3):379-85 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources